Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVO) Cash & Equivalents (2019 - 2025)

Evotec SE (EVO) has disclosed Cash & Equivalents for 7 consecutive years, with $487.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 50.55% to $487.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $487.2 million through Dec 2025, up 50.55% year-over-year, with the annual reading at $487.2 million for FY2025, 50.55% up from the prior year.
  • Cash & Equivalents hit $487.2 million in Q4 2025 for Evotec SE, up from $323.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $800.0 million in Q4 2021 to a low of $323.6 million in Q4 2024.
  • Historically, Cash & Equivalents has averaged $516.8 million across 5 years, with a median of $487.2 million in 2025.
  • Biggest five-year swings in Cash & Equivalents: soared 58.78% in 2021 and later plummeted 47.06% in 2022.
  • Year by year, Cash & Equivalents stood at $800.0 million in 2021, then tumbled by 47.06% to $423.6 million in 2022, then rose by 29.78% to $549.7 million in 2023, then tumbled by 41.13% to $323.6 million in 2024, then skyrocketed by 50.55% to $487.2 million in 2025.
  • Business Quant data shows Cash & Equivalents for EVO at $487.2 million in Q4 2025, $323.6 million in Q4 2024, and $549.7 million in Q4 2023.